Busan, South Korea

Sillajen, Inc.


USPTO Granted Patents = 4



Trademarks = 4

Forward Citations = 3

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal John Cameron Bell (2 out of 30 patents)

silverMedal Nam Hee Lee (2 out of 2 patents)

bronzeMedal Caroline Breitbach (2 out of 4 patents)

4 Anne Moon (2 out of 2 patents)

5 Tae-Ho Hwang (2 out of 2 patents)

6 Yu Kyoung Lee (2 out of 2 patents)

7 Mi-kyung Kim (2 out of 2 patents)

8 Tae Ho Hwang (2 out of 3 patents)

9 David H Kirn (2 out of 19 patents)

10 Euna Cho (1 out of 1 patent)

11 Mong Cho (1 out of 1 patent)

12 Ungbae Jeon (1 out of 1 patent)

13 Doo Jin Byun (1 out of 2 patents)

14 Hongjae Jeon (0 patent)

15 Eun Sang Moon (0 patent)


4 patents:

Sillajen, Inc. is a biotechnology company focused on developing and commercializing oncolytic immunotherapy products for the treatment of cancer. Their lead product candidate, Pexa-Vec, is currently in clinical trials for various types of cancer. Sillajen is dedicated to advancing innovative therapies to improve the lives of patients with cancer.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

4 Patents

#34 in Busan

#2,082 in South Korea

...
Busan, South Korea
Forward Citations = 3

32 inventors:

Please report any incorrect information to support@idiyas.com
Loading…